Skip to main content
SpringerLink
Log in

Money in biomedicine: The senator's sleuth

  • News Feature
  • Published:

From Nature

View current issue Submit your manuscript

Paul Thacker, a reporter-turned-Congressional-investigator, has disrupted the careers of several top researchers with lucrative industry ties. Meredith Wadman tracks his effect on US science.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Meredith Wadman
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

See Editorial, page 315 .

Related links

Related links

Related external links

Senate Finance Committee compendium of hyperlinks to Nemeroff-related documents

Senate Finance Committee archive of news stories by targeted investigator

Emory University index of hyperlinks on conflict and Nemeroff-related announcements

National Institutes of Health proposed rules changes on conflict disclosure for extramural investigators

SE Journal, summer 2007: Thacker's account of his ouster from Environmental Science and Technology, and Rudy Baum's written response

Association of Clinical Researchers and Educators

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wadman, M. Money in biomedicine: The senator's sleuth. Nature 461, 330–334 (2009). https://doi.org/10.1038/461330a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/461330a

  • Springer Nature Limited

Search

Navigation